ABSTRACT
INTRODUCTION 58
Toxoplasma gondii (T. gondii) is an opportunistic pathogen that causes encephalitis or 59 debilitating ocular and congenital diseases in humans (1-4). It has also been implicated as 60 a risk factor for schizophrenia and other major mental illnesses (5-8). The parasite 61 progresses through two major life stages during infection of its intermediate hosts: the 62 acute stage characterized by actively replicating tachyzoites and the chronic stage 63 featuring slow growing bradyzoite cysts that persist in muscle and brain tissue (9). While 64 drugs exist against acute stage tachyzoites, currently no treatments are available to 65 combat the chronic stage bradyzoite cysts. The development of new interventions for 66 limiting disease from chronic infection is hindered by a lack of well-validated potential 67 targets and understanding of the biology of T. gondii bradyzoites. 68 puncta (13). We found that P∆crt cysts treated with LHVS developed dark puncta and that 216 this corresponded with loss of the translucent VAC ( Fig. 5A and B ). As expected, there 217 was an increase in dark puncta of parental and complement LHVS treated cysts as well. 218
However, P∆crt cysts contain larger dark puncta in both DMSO and LHVS treated samples 219 than in the parental and complement cysts (Fig. 5B) . Also, although P∆crt bradyzoites did 220 not show an increase in the total number of puncta (Fig. 5C ), the percentage of total cyst 221 area occupied by puncta was increased with LHVS treatment (Fig. 5D ). Together these 222 findings suggest that P∆crt bradyzoites have larger puncta as an indicator of undigested 223 material; however, whether this is a result of moderately impaired proteolytic digestion 224 within the VAC or the intrinsically larger size of P∆crt VAC is unclear. 225
226
The dark puncta observed within LHVS-treated bradyzoite cysts have been shown to co-227 localize with TgCPL and T. gondii autophagy-related protein 8 (TgAtg8), suggesting that 228 some of the undigested material found within the bradyzoite VAC is derived from 229 autophagy (13). To interrogate whether TgCRT deficiency affects the production or 230 turnover of parasite autophagosomes, we created a PΔcrt strain that ectopically expresses 231 tdTomato-TgAtg8 (Fig. S2) , as done previously for Pru (13). Abundance of tdTomato-232
TgAtg8 in DMSO treated bradyzoites is a function of autophagosomal production and 233 turnover. By contrast, tdTomato-TgAtg8 abundance in LHVS treated bradyzoites is a 234 function of autophagosomal production exclusively since turnover is blocked. Pru-and 235
PΔcrt tdTomato-TgAtg8 cysts treated with DMSO or LHVS for 1 or 3 days were assessed 236 for tdTomato-TgAtg8 intensity both within cysts and in isolated bradyzoites. We also 237 measured the total area of tdTomato-TgAtg8 puncta within cysts. For the DMSO control, 238 no significant differences were seen between Pru and PΔcrt parasites for tdTomato 11 TgAtg8 intensity in intact cysts ( Fig. 6A & B) or isolated bradyzoites (Fig. 6C) , suggesting 240 no change in the balance of autophagosome production and turnover. DMSO treated PΔcrt 241 bradyzoites showed a modest, but significant, increase in tdTomato-TgAtg8 puncta size 242 (Fig. 6D) , potentially due to tdTomato-TgAtg8 association with the enlarged VAC in such 243 parasites. Upon inhibition of VAC proteolysis with LHVS, tdTomato-TgAtg8 intensity and 244 size increased progressively for both Pru and PΔcrt bradyzoites. However, accumulation of 245 tdTomato-TgAtg8 in PΔcrt bradyzoites was delayed and somewhat muted compared to 246
Pru. Taken together, these data suggest that the balance of autophagosome production 247 and turnover is unchanged in P∆crt, but that TgCRT deficiency is associated an overall 248 lower rate of autophagosome production. TgCRT is also able to transport amino acids and small peptides out of the VAC. If TgCRT 258 plays a similar role and the swelling of the VAC in PΔcrt parasites is due to a buildup of 259
TgCRT substrates derived from protein digestion, then reducing the production of digestion 260 products by inhibiting TgCPL should prevent or reverse VAC enlargement. 261
12
To test this, we differentiated PΔcrt bradyzoites 7 days before adding LHVS for another 2 263 days under differentiation conditions. This treatment window was chosen because our 264 earlier results showed that 3 days of LHVS treatment results in larger dark and Atg8 265 puncta areas (Fig. 5B & 6D) , whereas a 1 day treatment appeared to have no notable 266 effect on Atg8 intensity (Fig. 5B & C) . We reasoned that with 2 days of treatment, we 267 should begin seeing an effect of LHVS treatment on VAC size prior to excessive 268 accumulation of undigested protein. Although some enlarged VACs were apparent in 269 LHVS treated P∆crt bradyzoites (Fig. 7A ), quantification revealed a significant restoration 270 of VAC size upon LHVS treatment (Fig. 7B) . Also, undigested material accumulated within 271 the VAC of P∆crt bradyzoites treated with LHVS, suggesting that TgCPL is active in P∆crt 272
bradyzoites. 273 274
To validate a link between TgCRT transport function and VAC proteolysis, we compared 275 the size and appearance of the VAC in P∆crt bradyzoites with that of Pru or P∆crt∆cpl 276 parasites. We found that after 4 or 7 days of conversion to bradyzoite cysts, PΔcrtΔcpl 277 bradyzoites have visually smaller VACs full of electron-dense, undigested material 278 compared to the markedly enlarged, more electron-lucent VACs of P∆crt bradyzoites (Fig.  279   7C) . Quantification revealed VAC size of PΔcrtΔcpl strains to be significantly smaller than 280 PΔcrt VACs at both time points (Fig. 7D ). These findings indicate that by genetically 281 limiting proteolysis in the VAC, the gross enlargement of the VAC observed in PΔcrt 282 bradyzoites is prevented. In addition, whereas approximately 20% P∆crt cysts were dead 283 or dying at both 4 and 7 days post-conversion, 75% of PΔcrtΔcpl cysts were degenerate at 284 a manner that is consistent with TgCRT acting as an exporter of degradation products 288 generated by VAC proteases in bradyzoites. 289
290

DISCUSSION 291
Herein we show that TgCRT is necessary for maintaining the size of the VAC and the 292 viability of T. gondii bradyzoites, possibly by functioning as a transporter of digested 293 material from the VAC to the parasite cytosol. Together with other recent studies reporting 294 that VAC protein digestion is crucial for bradyzoite viability (13), our findings point toward 295
the VAC as an important organelle for T. gondii bradyzoite persistence and uncover 296
TgCRT as a potential target for chronic T. gondii infection. 297
298
Our finding that deletion of TgCRT in a type II strain (P∆crt) resulted in enlargement of the 299 VAC is in line with previous studies that have knocked down (15) or knocked out (18) 300
TgCRT in a type I strain (RH). We also show that this enlarged VAC phenotype is 301 consistent across life stages and that it appears to be especially prominent in bradyzoites. 302
Our EM measurements suggest that the VAC occupies one third of the cytoplasm of P∆crt 303 bradyzoites, thus becoming easily visible by phase contract microscopy in many parasites. 304 VAC enlargement was fully reversed upon re-expression of TgCRT, firmly establishing that 305
TgCRT expression is necessary to maintain normal VAC morphology. TgCRT deficient bradyzoites. Nevertheless, we noted a delay in the accumulation of the 380 autophagic marker TgAtg8 in PΔcrt bradyzoites after blocking TgCPL activity with LHVS, 381 suggesting a decrease in the production of autophagosomes. Whether this is a result of a 382 feedback loop to reduce delivery of substrates to the VAC akin to the down-regulation of 383 proteases in TgCRT deficient tachyzoites (18) or a due to a general decline in the health of 384
PΔcrt bradyzoites remains unclear. It should also be noted that although we were unable 385 to introduce tdTomato-TgAtg8 into P∆crt:CRT parasites due to a lack of available 386 selectable markers, all of the other phenotypes measured in PΔcrt parasites were restored 387 upon genetic complementation. 
MATERIALS AND METHODS 398
Host cell and parasite cultures. Human foreskin fibroblasts (HFFs) were grown in 399
Dulbecco's Modified Eagle Medium (DMEM, Gibco) containing 10% cosmic calf (Gibco), 400 50 µg/ml penicillin-streptomycin, 2 mM L-glutamine, and 10 mM HEPES. T. gondii strains 401 used in this study were derived from PruS/Luc strain (13) maintained in vitro by serial 402 passage on human foreskin fibroblast (HFF) monolayers as previously described (23 plaque assays normalized to qPCR as previously described (13). Briefly, tachyzoites were 423 converted to bradyzoite cysts for 7 and 14 days as described above. At these time points 424 bradyzoites were harvested using pepsin treatment and added to HFF monolayers for 10 425 days, after which time plaques were counted. Genomic DNA was extracted from an aliquot 426 of samples using the Qiagen Blood and Tissue Kit and SYBR Green qPCR performed 427 using the primer pairs listed in Table S1 and the following procedures, counted, and added to HFF monolayers in triplicate to quadruplicate wells.
made from freshly lysed Pru tachyzoites that was sonicated in 1 ug/mL Leupeptin, 1 ug/mL 457 E64, TPCK, and 10 ug/mL A-PMSF. Plates were coated with 10 ng of antigen in coating 458 buffer (Na 2 CO 3 , NaHCO 3 , pH 9.6) overnight, blocked in 3% gelatin/PBS-T, serum was 459 added in a 1:25 dilution in 1% gelatin/PBS-T and incubated for 1 hr at RT. Secondary 460 HRP-conjugated GtαMs (1:1000) was added for 1 hr. Substrate was added for color 461 development, which was stopped with H 2 SO 4 . Absorbance was read at 400 nm. Noise was reduced by opening the image with 6 iterations of one pixel. Masks were 487 created by using the Analyze Particle function, with objects between 130 -1900 µm 2 , and 488 a circularity of 0.30-1.00 begin called a cyst. Under these masks, dark puncta were 489 analyzed in the following way: phase images were Guassian blurred with a sigma of 2, and 490 then auto-local thresholding was performed using the Phansalkar method (28) with a 491 radius of 5 pixels. Objects with an area of 0.20 -6.00 µm 2 and a circularity of 0.50 -1.00 492 were analyzed as dark puncta. 493
494
In vitro differentiation kinetics. Tachyzoites were converted to bradyzoite cysts as 495 described above. Parasites were fixed at 1, 2, 3, and 4 days post-conversion and stained 496 for BAG1 (RbαBAG1, 1:1000), a late marker for bradyzoites. These parasites express 497
GFP under the LDH2 promoter, an early marker of bradyzoites. Image J was used to 498
analyze the BAG1 and GFP coverage of each vacuole. Vacuoles were manually identified 499 using phase images by drawing an ROI with the freehand tool. The ROIs were then 500 applied to other channels for analysis as follows. The GFP and Texas Red channels were22 thresholded and thresholded ROIs were measured for pixel intensity and used to 503 determine overall and percent intensity for GFP and Texas Red. Vacuoles with over 50% 504 coverage were designated as being cysts, and the total percentage of GFP and BAG1 505 positive cysts was calculated independently. 506
507
In vivo cyst burden. C57BL/6J female mice (7-8 wks old, Jackson Laboratories, Bar 508
Harbor, ME) were used in this study. Mice were injected intra-peritoneum (i.p.) with purified 509 
experiments. 516 517
In vivo parasite burden kinetics. The same inoculation conditions as described for in 518 vivo cyst burden was used. At 7 and 10 days post-infection (dpi) mice were sacrificed and 519 brains harvested. Brains were homogenized in ice-cold PBS to have 50 ng homogenate/µL 520 PBS. gDNA was extracted from 50 µL of homogenate using the DNeasy Blood and Tissue 521 Kit (Qiagen). qPCR was performed in triplicate for each sample with the following cycling 522 conditions: 90°C, 2'; [98°C, 10"; 56°C, 20"; 72°C,20"]x45 using SSO Advanced SYBR 523
Green Supermix (BioRad), and 300 nM Tox9 and 11 primers listed in Table S1 . T. gondii 524 standards of specified parasite numbers (1 -10 5 genomes/µL) were used to quantify 525 parasite brain burden. 526 cyst burden experiment, 5 and 30 brain cysts of Pru, PΔcrt, or PΔcrt:CRT were injected i.p. 529 into C57BL/6J female mice (7-8 weeks old). Mice inoculated with an equivalent amount of 530 uninfected mouse brain homogenate were used as a negative control for infection. At 3 wpi 531 mice were coded and sacrificed. Serum and brain was collected as described above for 532 the in vivo cyst burden. Half of each brain homogenate was added to confluent HFF cells 533 and monitored for parasite growth for 4.5 weeks. A. Electron microscopy of in vitro bradyzoite cysts converted for 7 days and then 772 Table S1 . Primer sequences and PCR product sizes. 787 Table S1 . 795 Table S1 . 
